1,527
Views
1
CrossRef citations to date
0
Altmetric
Immunotherapeutics – Case Report

PD-1 inhibitor treatment in a penile cancer patient with MMR/MSI status heterogeneity: A case report

, , , , , & show all
Article: 2121122 | Received 16 Jul 2022, Accepted 23 Aug 2022, Published online: 26 Sep 2022